HIGH POINT, NC -- When high school senior Siobhan O'Dell got rejected from Duke University, she thought it'd be funny to give them a taste of its own medicine. So she sent them a letter to inform them ...
RGX-121 was rejected in early February, with Regenxbio listing the primary reasons given by the FDA as concerns about the ability to properly define a patient population, the use of a natural history ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results